electroCore, Inc.
Change company Symbol lookup
Select an option...
ECOR electroCore, Inc.
OSUR OraSure Technologies Inc
KO Coca-Cola Co
VICI VICI Properties Inc
PLT Plantronics Inc
THG Hanover Insurance Group Inc
USB U.S. Bancorp
BAC Bank of America Corp
TCNNF Trulieve Cannabis Corp
RM Regional Management Corp
Go

Company profile

ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.

Price
Delayed
$1.48
Day's Change
0.0103 (0.70%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.51
Day's Low
1.40
Volume
(Below Average)

Today's volume of 262,563 shares is on pace to be lower than ECOR's 10-day average volume of 371,180 shares.

262,563

Display:

Providers:

UpdateCancel
6 providers
October 21, 2020
electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business Unit

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the appointment of Sylvester "Sly" Steele to the newly created position of Vice President and General Manager of the Government Channels Business...(Globe Newswire)

October 13, 2020
electroCore Provides Business Update and Select Financial Guidance

Third quarter 2020 Revenue expected to exceed $1 million, representing an increase of greater than 35% sequentially and greater than 50% over Q3 2019 Operating cash burn for the third quarter 2020 of approximately $4.1 million (Globe Newswire)

October 08, 2020
The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020

NEW YORK, NY / ACCESSWIRE / October 8, 2020 / The MicroCap Rodeo continues this year with its first virtual event set for October 13-16, 2020. This year' "Best Ideas" conference focuses solely on 25 public companies recommended by institutional...(Accesswire)

October 06, 2020
electroCore to Participate in the MicroCap Rodeo: The Best Ideas Bowl

BASKING RIDGE, NJ / ACCESSWIRE / October 6, 2020 / electroCore, Inc. (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will provide a corporate update at the MicroCap...(Accesswire)

October 01, 2020
electroCore, Inc. Announces Extension of NHS England's Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore(TM) in England

ITP program providing reimbursement for gammaCore(TM) extended to March. 31, 2021 with option for additional three years The potential contract value if the three-year extension option is exercised could be up to approximately £3.6 million (or...(Globe Newswire)

September 30, 2020
electroCore Announces Department of Veterans Affairs Sponsored Study of Non-Invasive Vagal Nerve Stimulation (nVNS) in Mild Traumatic Brain Injury (mTBI) and Post-Traumatic Stress Disorder (PTSD)

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Department of Veterans Affairs has agreed to sponsor a quadruple blind, randomized, sham-controlled clinical trial of non-invasive vagal...(Globe Newswire)

September 24, 2020
electroCore Announces Agreement with UpScript, LLC to be Exclusive Online Telehealth Provider for gammaCore Sapphire(TM) CV

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into exclusive agreement with UpScript, LLC in which UpScript will serve as the exclusive online telehealth provider for...(Globe Newswire)

September 23, 2020
electroCore to Participate in the JMP Securities MedTech Bio Summit

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held...(Globe Newswire)

September 11, 2020
electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held from September...(Globe Newswire)

August 31, 2020
LD Micro -- 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.(Accesswire)

August 26, 2020
electroCore to Present at The LD 500 Virtual Conference

LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / electroCore Inc, (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 6:20 AM...(Accesswire)

August 24, 2020
electroCore, Inc. Announces Publication of a Voluntary ex-ante Transparency Tender Notice Award by NHS England to Fund Continued Use of gammaCore(TM) in England

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Official Journal of the European Union (OJEU) has published a Voluntary ex-ante Transparency Tender Notice on behalf of NHS England...(Globe Newswire)

August 13, 2020
electroCore Announces Second Quarter Financial Results

Received EUA and initiated gammaCore Sapphire CV distribution process for certain known or suspected COVID-19 patients experiencing asthma exacerbations Generated sequential increase in revenue Further strengthened balance sheet and reduced...(Globe Newswire)

August 06, 2020
electroCore to Announce Second Quarter Ended June 30, 2020 Financial Results on Thursday, August 13

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter ended June 30, 2020 after the close of the market on Thursday, August 13, 2020. Management...(Globe Newswire)

August 05, 2020
LD Micro - Announces Preliminary List of Presenters for the LD-500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.(Accesswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.